ALLMedicine™ Postherpetic Neuralgia Center

Jun 26th, 2022 - Studies on functional and structural changes in the primary somatosensory cortex (S1) have provided important insights into neural mechanisms underlying several chronic pain conditions. However, the role of S1 plasticity in postherpetic neuralgia ...

Jun 21st, 2022 - This study aims at investigating the internal heat acupuncture (IHA) combined with the high-voltage long-duration pulsed radiofrequency (PRF) therapeutic effect on subacute postherpetic neuralgia (PHN). This retrospective study comprised 81 cases ...

Jun 21st, 2022 - Evaluation of the efficacy of LX9211 compared to placebo in reducing pain related to postherpetic neuralgia over an 11 week assessment period.

Jun 16th, 2022 - Neuropathic pain is a debilitating symptom reported by patients presenting with postherpetic neuralgia (PHN). Efforts to alleviate this pain have been projected to lie in individualization of pharmacological treatment through pain phenotyping and ...

Jun 11th, 2022 - This study evaluated the effectiveness and safety of botulinum toxin type A (BoNT-A) and pulsed radiofrequency (RF) in the clinical treatment of postherpetic neuralgia (PHN). A total of 100 patients with PHN were randomly divided into two groups (...

Nov 3rd, 2016 - Herpes zoster (HZ, shingles) is a frequent medical condition which may severely impact the quality of life of affected patients. Different therapeutic approaches to treat acute HZ are available. The aim of this European project was the elaboration...

Aug 13th, 2014 - The Neuromodulation Appropriateness Consensus Committee (NACC) of the International Neuromodulation Society (INS) evaluated evidence regarding the safety and efficacy of neurostimulation to treat chronic pain, chronic critical limb ischemia, and r...

Jun 12th, 2013 - Neuropathic pain (NP) is often refractory to pharmacologic and noninterventional treatment. On behalf of the International Association for the Study of Pain Neuropathic Pain Special Interest Group, the authors evaluated systematic reviews, clinica...

Jun 21st, 2022 - Evaluation of the efficacy of LX9211 compared to placebo in reducing pain related to postherpetic neuralgia over an 11 week assessment period.

Jun 9th, 2022 - Botulinum toxin type A (BoNT-A) is widely used to treat muscle hyperactivity, based on its ability to inhibit synaptic exocytosis and, therefore, to disable neural transmission. Further research has shown that BoNT-A has analgesic properties indep...

May 31st, 2022 - Recently, a live-attenuated vaccine (Zostavax®, Merck) to prevent herpes zoster (HZ) has been developed and approved for use among individuals age 50 years or older, regardless of previous HZ or varicella history. In a pivotal study of 38,456 olde...

May 31st, 2022 - The study will evaluate the efficacy and safety of SR419 in PHN patients. Each subject will participate in the study for up to approximately 14 weeks. This includes a screening period, drug treatment period, and post-treatment safety follow-up per...

Apr 15th, 2022 - Postherpetic neuralgia(PHN) is the most common complication of herpes zoster, is a severe and intractable pain with a high incidence. Nearly 50% of PHN patients have experienced persistent pain for more than one year. Although it is not directly l...

May 10th, 2022 - ILLUSTRATIVE CASE A 23-year-old man with no significant past medical history presents to an urgent care center after a fall on his right arm while playing football. He reports a pain level of 6 using the visual analog scale (VAS).

Apr 1st, 2022 - Mr. B, age 64, is being treated in the psychiatric clinic for generalized anxiety disorder.

Mar 22nd, 2022 - In January 2022, the Centers for Disease Control and Prevention (CDC) updated recommendations for shingles (herpes zoster) vaccination to include people 19 years and older who are or will be immunocompromised. This will enable providers to vaccina...

Feb 4th, 2022 - Herpes zoster, or shingles, is a painful viral infection that occurs via the reactivation of varicella zoster virus. Approximately 30% of the world's population will develop herpes zoster during their lifetime, making it a significant global healt...

Feb 4th, 2022 - Herpes zoster, or shingles, is a painful viral infection that occurs via the reactivation of varicella zoster virus. Approximately 30% of the world's population will develop herpes zoster during their lifetime, making it a significant global healt...